1.NounAny of several molecular analogues of endogenous insulin with similar insulin receptor ligand activity but suitable for differing time spans of bioavailability and action; produced recombinantly and used as medications in treating diabetes; often metonymically just called insulin, the molecular modifications notwithstanding.